Paul R. Kirchgraber - Insider Trading & Ownership

Entity
Individual
Location
531 South Spring Street, Burlington, NC
Summary
The estimated net worth of Paul R. Kirchgraber is at least $2.84M dollars as of May 23, 2023. Paul R. Kirchgraber is the CEO, Covance Drug Development of LABORATORY CORP OF AMERICA HOLDINGS and owns shares of LABCORP HOLDINGS INC. (LH) stock worth about $2.84M.
All Insider Reports
All Insider Reports

Ownership of Paul R. Kirchgraber

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LH LABCORP HOLDINGS INC. CEO, Covance Drug Development $2.84M May 19, 2023

Insider Transactions Reported by Paul R. Kirchgraber:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.